FIRST WORLDWIDE EPIDEMIOLOGICAL STUDY
ON ECZEMA PATIENTS
TO HIGHLIGHT THE INVISIBLE SCARS
THAT IMPACT PATIENTS THROUGHOUT THEIR LIVES
30,801
PARTICIPANTS
27
COUNTRIES
4,000,000
DATA POINTS
IN PARTNERSHIP WITH 15 WORLDWIDE EXPERTS AND NATIONAL PATIENT ASSOCIATIONS
7,840
WITH ECZEMA IN CHILDHOOD/TEENAGE AND ADULTHOOD
7,610
WITH ECZEMA IN CHILDHOOD/TEENAGE BUT NOT IN ADULTHOOD
7,383
WITH ECZEMA IN ADULTHOOD BUT NOT IN CHILDHOOD/TEENAGE
7,968
WITHOUT ECZEMA DURING CHILDHOOD/TEENAGE AND ADULTHOOD
OUR RESEARCH CLEARLY DEMONSTRATES THAT ADULTS WHO HAVE BATTLED ECZEMA SINCE CHILDHOOD EXPERIENCE HIGHER LEVELS OF STIGMATIZATION (PER PUSH-D SCORE EVALUATION) AND MORE SIGNIFICANT LONG-TERM IMPACTS ON THEIR DAILY LIVES (AS MEASURED BY THE 'SCARS OF LIFE' EVALUATION).
WE HAVE A ROLE TO PLAY IN ENSURING THAT THESE INDIVIDUALS RECEIVE COMPREHENSIVE SUPPORT TO ADDRESS BOTH THE VISIBLE AND INVISIBLE CHALLENGES OF LIVING WITH ECZEMA.